Int J Risk Saf Med
March 2024
Background: Data about performance measures (PM) in patients with ST segment Elevation Myocardial Infarction (STEMI) in low- and middle-income countries is really scarce. One of the reasons is the lack of appropriate measures for these scenarios where coronary intervention is not the standard treatment.
Objective: This study aimed to develop a set of PM and quality markers for patients with STEMI in these countries.